Vista Oncology

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Diffuse large B-cell lymphoma1 trial
• Lung cancer1 trial
• Pancreatic cancer1 trial

Phase

• Phase 22 trials
• Phase 1/21 trial
• Phase 31 trial

Status

• Active, not recruiting3 trials
• Recruiting1 trial

Lead sponsor

• Astellas Pharma Global Development, Inc.1 trial
• Genmab1 trial
• Incyte Corporation1 trial
• Janssen Research & Development, LLC1 trial

Running trials

• Recruiting

  Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)

  NCT07702032· Phase 3· Genmab· Source

• Recruiting

  A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT06667076· Phase 2· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients

  NCT05222555· Phase 1/2· Incyte Corporation· Source

• Active, not recruiting

  A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

  NCT03816163· Phase 2· Astellas Pharma Global Development, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting